Table 1. Our test set is comprised of proteins for which structures have been solved both alone and in complex with a small-molecule inhibitor bound to the protein interaction site.
Protein | Partner | Number of residues | Number of residues used in simulations | Deep pocket volume from unbound protein structure (Å3) | Deep pocket volume from protein-protein complex (Å3) | Deep pocket volume from inhibitor-bound complex (Å3) | Deep pocket volume from conformations generated via biased simulations (the 5% with lowest energy) (Å3) | Affinity of most potent known inhibitor (nM) |
MDM2 | p53 | 492 | 119 | 129 | 150 | 201 | 194 | 80 |
ZipA | FtsZ | 328 | 139 | 91 | 166 | 61 | 92 | 12,000 |
Bcl-xL | Bak | 233 | 141 | 200 | 377 | 342 | 210 | 0.5 |
XIAP | SMAC | 497 | 117 | 158 | 27 | 40 | 323 | 67 |
IL-2 | IL-2R | 153 | 128 | 38 | 38 | 38 | 177 | 60 |
HPV E2 | HPV E1 | 367 | 193 | 93 | 92 | 132 | 129 | 40 |
FKBP12 | Tbeta1-R | 108 | 107 | 90 | 124 | 145 | 116 | 7 |